Cinclus Pharma Holding Ab
Clinical trials sponsored by Cinclus Pharma Holding Ab, explained in plain language.
-
New GERD pill aims to keep esophagus healed longer
Disease control Not yet recruitingThis study tests a new drug, linaprazan glurate, to see if it can keep the esophagus healed in people with GERD-related erosive esophagitis better than the standard treatment lansoprazole. About 1050 adults who have already healed their esophagitis will take either high or low do…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 26, 2026 10:06 UTC
-
New GERD drug aims to heal esophagus faster than current treatment
Disease control Not yet recruitingThis study tests a new medicine called linaprazan glurate to see if it heals esophagus damage from GERD better than the standard drug lansoprazole. About 500 adults with erosive esophagitis will take either the new drug or the standard one for up to 8 weeks. Doctors will use came…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 15, 2026 11:56 UTC